{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:21:54Z","timestamp":1779891714416,"version":"3.53.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13014-017-0904-y","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T19:40:40Z","timestamp":1511206840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Comparison of neoadjuvant chemoradiation with carboplatin\/ paclitaxel or cisplatin\/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagus"],"prefix":"10.1186","volume":"12","author":[{"given":"Stefan","family":"M\u00fcnch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffi U.","family":"Pigorsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Feith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Slotta-Huspenina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilko","family":"Weichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Friess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie E.","family":"Combs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Habermehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,21]]},"reference":[{"issue":"5","key":"904_CR1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359\u201386.","journal-title":"Int J Cancer"},{"issue":"7","key":"904_CR2","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1200\/JCO.2007.12.9593","volume":"26","author":"J Tepper","year":"2008","unstructured":"Tepper J, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol. 2008;26(7):1086\u201392.","journal-title":"J Clin Oncol"},{"issue":"22","key":"904_CR3","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","volume":"366","author":"P van Hagen","year":"2012","unstructured":"van Hagen P, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074\u201384.","journal-title":"N Engl J Med"},{"issue":"4","key":"904_CR4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/dote.12110","volume":"27","author":"RL Blom","year":"2014","unstructured":"Blom RL, et al. Comparison of two neoadjuvant chemoradiotherapy regimens in patients with potentially curable esophageal carcinoma. Dis Esophagus. 2014;27(4):380\u20137.","journal-title":"Dis Esophagus"},{"issue":"7","key":"904_CR5","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/cncr.11660","volume":"98","author":"K Becker","year":"2003","unstructured":"Becker K, et al. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer. 2003;98(7):1521\u201330.","journal-title":"Cancer"},{"issue":"2","key":"904_CR6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.6004\/jnccn.2015.0028","volume":"13","author":"JA Ajani","year":"2015","unstructured":"Ajani JA, et al. Esophageal and esophagogastric junction cancers, version 1.2015. J Natl Compr Cancer Netw. 2015;13(2):194\u2013227.","journal-title":"J Natl Compr Cancer Netw"},{"key":"904_CR7","doi-asserted-by":"crossref","unstructured":"Porschen R. et al. [Not Available]. Z Gastroenterol. 2015 53(11): 1288-1347.","DOI":"10.1055\/s-0041-107381"},{"issue":"1","key":"904_CR8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1200\/JCO.1996.14.1.156","volume":"14","author":"BA Bates","year":"1996","unstructured":"Bates BA, et al. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol. 1996;14(1):156\u201363.","journal-title":"J Clin Oncol"},{"issue":"3","key":"904_CR9","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/annonc\/mdt589","volume":"25","author":"J Honing","year":"2014","unstructured":"Honing J, et al. A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients. Ann Oncol. 2014;25(3):638\u201343.","journal-title":"Ann Oncol"},{"issue":"9","key":"904_CR10","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","volume":"16","author":"J Shapiro","year":"2015","unstructured":"Shapiro J, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16(9):1090\u20138.","journal-title":"Lancet Oncol"},{"issue":"10","key":"904_CR11","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2005.04.7118","volume":"25","author":"L Bedenne","year":"2007","unstructured":"Bedenne L, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007;25(10):1160\u20138.","journal-title":"J Clin Oncol"},{"issue":"7","key":"904_CR12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00066-010-2137-y","volume":"186","author":"M Wolf","year":"2010","unstructured":"Wolf M, et al. Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer. Strahlenther Onkol. 2010;186(7):374\u201381.","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"904_CR13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13014-017-0785-0","volume":"12","author":"Y Xia","year":"2017","unstructured":"Xia Y, et al. A phase II study of concurrent chemoradiotherapy combined with a weekly paclitaxel and 5-fluorouracil regimen to treat patients with advanced oesophageal carcinoma. Radiat Oncol. 2017;12(1):47.","journal-title":"Radiat Oncol"},{"issue":"10","key":"904_CR14","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/sj.bjc.6603134","volume":"94","author":"E van Meerten","year":"2006","unstructured":"van Meerten E, et al. Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study. Br J Cancer. 2006;94(10):1389\u201394.","journal-title":"Br J Cancer"},{"key":"904_CR15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13014-015-0420-x","volume":"10","author":"T Zhang","year":"2015","unstructured":"Zhang T, et al. Double-arc volumetric modulated therapy improves dose distribution compared to static gantry IMRT and 3D conformal radiotherapy for adjuvant therapy of gastric cancer. Radiat Oncol. 2015;10:114.","journal-title":"Radiat Oncol"},{"issue":"10","key":"904_CR16","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00066-016-1020-x","volume":"192","author":"S Munch","year":"2016","unstructured":"Munch S, et al. Comparison of dosimetric parameters and toxicity in esophageal cancer patients undergoing 3D conformal radiotherapy or VMAT. Strahlenther Onkol. 2016;192(10):722\u20139.","journal-title":"Strahlenther Onkol"},{"issue":"6","key":"904_CR17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/dote.12144","volume":"27","author":"CY Lin","year":"2014","unstructured":"Lin CY, et al. Dosimetric and efficiency comparison of high-dose radiotherapy for esophageal cancer: volumetric modulated arc therapy versus fixed-field intensity-modulated radiotherapy. Dis Esophagus. 2014;27(6):585\u201390.","journal-title":"Dis Esophagus"},{"issue":"3","key":"904_CR18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199707173370304","volume":"337","author":"JF Bosset","year":"1997","unstructured":"Bosset JF, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med. 1997;337(3):161\u20137.","journal-title":"N Engl J Med"},{"issue":"10","key":"904_CR19","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1002\/cncr.11759","volume":"98","author":"SG Urba","year":"2003","unstructured":"Urba SG, et al. Concurrent cisplatin, paclitaxel, and radiotherapy as preoperative treatment for patients with locoregional esophageal carcinoma. Cancer. 2003;98(10):2177\u201383.","journal-title":"Cancer"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-017-0904-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T19:40:50Z","timestamp":1511206850000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-017-0904-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,21]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["904"],"URL":"https:\/\/doi.org\/10.1186\/s13014-017-0904-y","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,21]]},"article-number":"182"}}